Unlike many other screening and diagnostic methods, Aqsens Health’s E-TRF method is non-invasive. The method utilizes easily obtainable biological samples, such as saliva and urine, for analysis.

Sampling is also possible at home, which significantly brings down the price of the testing process.

Accurate and reliable results are the key in successful screening and diagnostics.

E-TRF’s chemical and biological sensors provide a comprehensive view of a disease, and can be used in addition to detection in classifying the severity or spread of a disease. In all of the tests conducted so far, our method’s remarkable sensitivity and specificity currently exceed the ones of many industry gold standard screening methods.

In order to make large scale screening possible both the test and testing process have to be scalable and low cost. E-TRF based screening tests provide unparalleled cost architecture, even for population level screening.

E-TRF based tests are significantly cheaper than tests offering equivalent performance, making large-scale screenings a feasible option both in developed and in developing economies.

Our method was designed from the very beginning to be fast – analyses are done without time-consuming pretreatment processes, the use of sensors is easy, and the results are delivered instantly.

In addition to quick testing, our development framework is also fast and agile, giving us and our research partners the opportunity to develop screening tests for multiple diseases simultaneously.